🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Softgel(s) Serving Size
90 Servings
Fat/Fatty Acid Product Type
20% Evidence Coverage

Supplement Facts — Evidence Check

Calories
20 {Calories}
Total Fat
2 g (3% DV)
Cholesterol
10 mg (3% DV)
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 1070mg UL 3000mg
Borage Oil
1000 mg

Other Ingredients

Softgel Capsule Vitamin E

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested Usage: 2 softgels 1-3 times per day or as directed by a health care professional.

⚠️ Warnings & Precautions

Sealed for your protection. Do not use if seal is broken.

🧪 Formulation Notes

Contains no artificial preservatives, colors or sweeteners; no dairy, gluten, wheat or yeast.

Omega-3 EPA 400 mg DHA 200 mg with Borage Oil

Additional Information

For freshness, store in a cool, dry place.

PURE POTENT TRUSTED TESTED

Bioclinic Naturals products are guaranteed to meet or exceed Good Manufacturing Practices (GMP) of the Canadian Government and the Therapeutic Goods Administration (TGA) regulations of Australia-among the world's highest standards for natural products.

LOT202555 EXPJN2012 Recyclable container. PRODUCT OF CANADA

Pharmaceutical Grade

R0

{recycle}

Product Details

UPC / SKU 6 29022 09361 8
DSLD Entry Date 2013-05-24
Product Type Fat/Fatty Acid
Form Softgel Capsule
DSLD ID 20888
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →